Irinotecan hydrochloride [USAN:JAN]

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

69 API Suppliers, 29 USDMF, 13 CEP/COS, 10 JDMF, 6 EU WC, 12 KDMF, 12 NDC API, 37 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

71 Drugs in Development

71 Drugs in Development

INTERMEDIATES

18 Intermediate Suppliers

18 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

219 FDF Dossiers, 65 FDA Orange Book, 93 Europe, 8 Canada, 14 Australia, 17 South Africa, 22 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

INJECTABLE;INJECTION - 100MG/5ML (20MG/ML), INJECTABLE;INJECTION - 300MG/15ML (20MG/ML), INJECTABLE;INJECTION - 40MG/2ML (20MG/ML), INJECTABLE, LIPOSOMAL;INTRAVENOUS - EQ 43MG BASE/10ML (EQ 4.3MG BASE/ML)

RELATED EXCIPIENT COMPANIES

1 Rochem International Inc, 2 SPI Pharma, 1 Gangwal Healthcare, 1 Nanjing Well Pharmaceutical, 1 Shanghai Minbiotech, 3 Actylis, 1 BioSpectra, 4 Nippon Fine Chemical, 11 Roquette, 1 Shijiazhuang Huaxu Pharmaceutical, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

9 Film Formers & Plasticizers, 7 Parenteral, 4 Taste Masking, 4 Coating Systems & Additives, 4 Fillers, Diluents & Binders, 3 Surfactant & Foaming Agents, 3 Emulsifying Agents, 2 Chewable & Orodispersible Aids, 2 Solubilizers, 2 Topical, 2 Co-Processed Excipients, 1 Direct Compression, 1 Thickeners and Stabilizers, 1 Dry Powder Inhalation, 1 Soft Gelatin